SO
ORIC icon

STRS Ohio’s Oric Pharmaceuticals ORIC Stock Holding History

STRS Ohio’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,400
Closed -$101K – 2058
2024
Q1 		$101K Sell
7,400
-500
-6% -$5.94K ﹤0.01% 1684
2023
Q4 		$72K Buy
+7,900
New +$57.1K ﹤0.01% 1733
2021
Q1 		– Sell
-5,400
Closed -$182K – 2250
2020
Q4 		$182K Buy
5,400
+3,200
+145% +$91.8K ﹤0.01% 1765
2020
Q3 		$55K Hold
2,200
– – ﹤0.01% 1952
2020
Q2 		$74K Buy
+2,200
New +$70.2K ﹤0.01% 1850

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's ORIC Position: Q2 2024 in Review

STRS Ohio sold out of Oric Pharmaceuticals (ORIC) in Q2 2024, closing a stake of 7,400 shares — an estimated $101K sold.

STRS Ohio first reported a position in ORIC in Q2 2020 and held it in 5 quarters. The position peaked at $182K in Q4 2020. 113 funds tracked by Wall St. Rank hold ORIC as of Q2 2024.

  • STRS Ohio reported no remaining Oric Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 7,400 Oric Pharmaceuticals shares in Q2 2024, an estimated $101K.
  • STRS Ohio first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • STRS Ohio's Oric Pharmaceuticals position peaked at $182K in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.